AbbVie

Open: 169.42 Close: 168.67 Change: -0.75

Our AI found unexpected things about AbbVie.

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, growth, high, CEO, Richard, Gonzalez, revenue, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

Revenues of $54.32 billion, down 5.9% year over year. Sales of oral migraine drug Ubrelvy were $234 million, up 18.9%.

Today's News

AbbVie will rely on its roster of growth products, including Humiras immunology heirs Rinvoq and Skyrizi, to help “absorb the largest loss of exclusivity event to date across our industry,” CEO Richard Gonzalez, added on the call with investors Friday. AbbVie reported revenues of $54.32 billion, down 5.9% year over year. Sales of oral migraine drug Ubrelvy were $234 million, up 18.9%. AbbVie Inc. reports mixed Q4 results; raises fy24 outlook. Abbvie reaffirms high single-digit CAGR through 2029. AbbVie expects to post adjusted earnings of $11.05 to $11.25 in 2024, which includes a 32 cent per-share dilutive impact from the proposed acquisitions of ImmunoGen and Cerevel Therapeutics. CEO Richard Gonzalez remains bullish on last years performance. AbbVie Inc. (ABBV) stock price, quote & news - stock analysis. Abbvie Inc.s highest dividend yield of 3.8% among domestic pharmaceutical companies experiencing significant top-line growth from 2024 to 2029. William Blair notes AbbVsies highest. dividend yield. among domestic. pharmaceutical companies with significant top line growth of $1.8%. AbbVie expects Botox market share to stay strong despite newer rivals. Analyst Consensus Moderate Buy Average Price Target: $172.77 ( 2.43% Upside ) Hedge Fund Trend Increased By 536.7K Shares Last Quarter. AbbVie on Friday stood by its previous guidance of high single-digit compound annual revenue growth through 2029. In 2024, Abbvie is well-positioned to fully absorb Humira erosion and achieve modest operational revenue growth, CEO Richard Gonzalez said in a statement.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, growth, high, CEO, Richard, Gonzalez, revenue, and the most common words in the summary are: stock, abbvie, market, top, earnings, price, abbv, . One of the sentences in the summary was: Sales of oral migraine drug Ubrelvy were $234 million, up 18.9%.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #stock #abbvie #market #top #earnings #price #abbv.